TABLE 1.
Characteristics of the patients.
| Total | IS * | PS * | ||
|---|---|---|---|---|
| n = 48 | n = 18 | n = 30 | p‐value | |
| Age, years (range) | 56 (10–75) | 54 (10–75) | 56 (15–66) | 0.25 |
| Sex, male/female, n | 30/18 | 10/8 | 20/10 | 0.44 |
| Indication for liver transplantation, n (%) | 0.57 | |||
| Liver cirrhosis | 25 (52.1%) | 7 (38.9%) | 18 (60.0%) | |
| Associated hepatocellular carcinoma | 10 (20.8%) | 5 (27.8%) | 5 (16.7%) | |
| Metabolic liver disease | 5 (10.4%) | 2 (11.1%) | 3 (10.0%) | |
| Fulminant hepatitis | 3 (6.3%) | 1 (5.6%) | 2 (6.7%) | |
| Others | 5 (10.4%) | 3 (16.7%) | 2 (6.7%) | |
| LDLT/DDLT, n | 43/5 | 15/3 | 28/2 | 0.27 |
| Donated liver, n right/left/posterior/whole liver | 28/10/5/5 | 9/5/1/3 | 19/5/4/2 | 0.43 |
| Number of anastomotic bile ducts, n 1/2/3 | 28/19/1 | 10/8/0 | 18/11/1 | 0.66 |
| Interval from transplantation to ERC, days (range) | 234 (83–5816) | 189 (83–5816) | 261 (87–1651) | 0.53 |
| Number of stricture improvements, n (%) | 21 (44%) | 5 (28%) | 16 (53%) | 0.08 |
| Number of stricture recurrences, n (%) | 8 (38%) | 2 (40%) | 6 (38%) | 0.92 |
Abbreviations: DDLT, deceased donor liver transplantation; ERC, endoscopic retrograde cholangiography; IS, inside stent; LDLT, living donor liver transplantation; PS, plastic stent.
*
The stent placed in the first ERC for biliary stricture after liver transplantation.